Compare Logitech International SA (LOGI) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Logitech International SA vs Health Care Select Sector SPDR Fund — how do they compare? Logitech International SA trades at $101.7 (market cap $14.65B), while Health Care Select Sector SPDR Fund trades at $160.19. The key difference: Logitech International SA pays a 1.67% dividend while Health Care Select Sector SPDR Fund pays none, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Logitech International SA nearer its low. Which is the better fit depends on your goals.
| LOGI | XLV | |
|---|---|---|
Market Cap | $14.65B | — |
Sector | Technology | — |
52-Week High | $126.69 | $164.48 |
52-Week Low | $85.84 | $129.01 |
Enterprise Value | $13.00B | — |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Logitech (LOGI) trades at $102.91, up 0.08% on the day, with a bullish technical signal from moving averages and support at $101. The company shows strong profitability with a 43.2% gross margin and 32.78% ROE, while recent earnings beats and a $1.36 dividend highlight financial health. Revenue is projected to grow to $4.8B in 2026, with net income reaching $711M.
Outlook remains positive with a consensus price target of $113, offering ~10% upside, driven by B2B and AI product growth. Risks include competitive pressures and reliance on consumer spending. Analyst sentiment is mixed with 26% buy ratings, suggesting cautious optimism amid solid fundamentals.
XLV trades at $159.25, down 1.14% with neutral technical signals overall. The healthcare ETF shows mixed momentum with bullish moving averages but neutral oscillators. Recent news highlights XLV's defensive characteristics amid market volatility, with State Street upgrading healthcare to positive for Q3 2026. The fund's diversified approach offers stability compared to more volatile biotech-focused alternatives.
XLV presents a defensive opportunity with lower costs and steady performance, though upside may be limited in the current cycle. Key risks include patent cliff concerns and sector rotation away from defensive plays if market sentiment improves. The ETF's broad healthcare exposure provides cushion against individual stock volatility while benefiting from pipeline innovations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Logitech International SA
Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
